Luminex Corporation, A DiaSorin Company, Austin, TX, United States.
Front Cell Infect Microbiol. 2022 Mar 24;12:862440. doi: 10.3389/fcimb.2022.862440. eCollection 2022.
The COVID-19 pandemic has brought about unprecedented changes to all facets of the healthcare system, including the diagnostic industry. The pandemic has highlighted both the challenges and strengths of the industry and has also provided valuable insights on how to be better prepared for future pandemics. In this perspective article, we describe the challenges faced by the diagnostic industry in general, particularly the difficulties encountered by Luminex Corporation, a diagnostic assay development and manufacturing company located in Austin, Texas, USA, as well as the mitigation strategies employed. In addition to discussion of the key challenges, the article provides insights on the lessons learned and steps that can be undertaken to better prepare for future outbreaks.
COVID-19 大流行给医疗保健系统的各个方面带来了前所未有的变化，包括诊断行业。这场大流行凸显了该行业的挑战和优势，也为如何更好地为未来的大流行做好准备提供了宝贵的见解。在这篇观点文章中，我们描述了诊断行业普遍面临的挑战，特别是位于美国德克萨斯州奥斯汀的诊断检测试剂开发和制造公司 Luminex 公司所遇到的困难，以及所采用的缓解策略。除了讨论主要挑战外，本文还提供了有关经验教训和可以采取的步骤的见解，以便为未来的疫情爆发做好更好的准备。
